Giovanni Marotta
Sunnybrook Health Sciences Centre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Giovanni Marotta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06014424 · Cannabidiol Medication Intervention TrialSunnybrook Health Sciences Centre · recruiting · Alzheimer Disease · principal investigator
- Ph3NCT04516057 · Nabilone for Agitation Blinded Intervention TrialSunnybrook Health Sciences Centre · recruiting · Alzheimer Disease, Agitation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 26 PubMed records, and a shared surname and initials can bring in a namesake. All 26 on PubMed
- 156 citationsRCR 5.1
- A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.Atherosclerosis · 199189 citationsRCR 3.3
- 5-Aza-2'-deoxycytidine (Decitabine) induces trilineage response in unfavourable myelodysplastic syndromes.Leukemia · 199386 citationsRCR 1.9
- Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.Haematologica · 200181 citationsRCR 1.9
- Minimally invasive surgery for Zenker diverticulum: analysis of results in 95 consecutive patients.Arch Surg · 199873 citationsRCR 4.2
- Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions.Eur J Nucl Med Mol Imaging · 200457 citationsRCR 2.0
- Brain networks underlining verbal fluency decline during STN-DBS in Parkinson's disease: an ECD-SPECT study.Parkinsonism Relat Disord · 200755 citationsRCR 1.8
- 46 citationsRCR 1.4
- Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy.J Transl Med · 201642 citationsRCR 1.8
- Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.Leukemia · 199741 citationsRCR 1.2